1 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Terminated 1 |
Follow GVHD,Acute: new trials by email Literature Review of GVHD,Acute trials Research Report on GVHD,Acute
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) TRX103 - Hematologic Malignancy, GvHD | Phase 1 | Recruiting | Tr1X, Inc. | 36 | 2024-04-08 | 2025-04-15 |
| Safety and Efficacy Study of hAESCs Therapy for aGVHD Human Amniotic Epithelial Stem Cell Injection - GVHD,Acute, aGVHD | Phase 1 | Completed | Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China | 10 | 2024-02-19 | 2026-10-15 |
| Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis WJ-MSC infusion - Allogeneic Disease, GVHD,Acute | Phase 1 | Unknown | Central Hospital, Nancy, France | 12 | 2023-09-01 | 2023-05-11 |
| Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD) OSSM-001 - GVHD,Acute | Phase 1 | Withdrawn | Ossium Health, Inc. | 2023-06-05 | 2022-12-23 | |
| A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease Itacitinib, Prednisone, Methylprednisolone - GVHD,Acute | Phase 1 / Phase 2 | Terminated | Innovent Biologics (Suzhou) Co. Ltd. | 1 | 2020-06-18 | 2020-10-29 |
Bronchiolitis Obliterans Syndrome (1) · Graft vs Host Disease (1) · Hematologic Neoplasms (1) · Leukemia, Myelomonocytic, Chronic (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)
Bone Marrow Diseases (1) · Bronchial Diseases (1) · Bronchiolitis (1) · Bronchiolitis Obliterans (1) · Bronchitis (1) · Chronic Disease (1) · Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Leukemia, Myeloid (1) · Lung Diseases (1)
Methylprednisolone (1) · Prednisone (1) · itacitinib (1)
Central Hospital, Nancy, France (1) · Innovent Biologics (Suzhou) Co. Ltd. (1) · Ossium Health, Inc. (1) · Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China (1) · Tr1X, Inc. (1)
China (2) · United States (1)
Maria Grazia Roncarolo, MD (1) · Sagar Munjal (1) · Xiaojun Huang, M.D., PhD (1)
2023 (1)